Closing the Case on STAP?

Several reports offer an inside look into the stem-cell research controversy.

Written byKaren Zusi
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

HARUKO OBOKATALast year, two Nature papers in which researchers reported having created pluripotent stem cells by stressing differentiated mouse cells were published, questioned, and subsequently retracted. The confusion led to multiple misconduct investigations and a media firestorm, and reportedly contributed to the death of one of the studies’ authors. A set of papers published today (September 23) in Nature brings to light additional details regarding the controversial stimulus-triggered acquisition of pluripotency—or STAP—research.

In their original articles (published in January 2014; retracted in July 2014), lead author Haruko Obokata of Japan’s RIKEN Center for Developmental Biology and her colleagues reported that exposure to an acid bath could reprogram mature cells into pluripotent STAP cells. Within weeks, other researchers reported difficulty reproducing the published protocols. (Obokata resigned from RIKEN in December 2014.)

As it turns out, contamination of the supposed STAP cells with embryonic stem cells may have been in part to blame. In one of the Nature commentaries published today, researchers from RIKEN and the Tokyo Institute of Technology examined this aspect of the STAP reproducibility problem.

“The publication and retraction of STAP papers strongly influenced the national scientific community, especially the stem-cell community. We felt that we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies